Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | KIT |
Variant | V559_V560del |
Impact List | deletion |
Protein Effect | gain of function |
Gene Variant Descriptions | KIT V559_V560del results in the deletion of two amino acids in the juxtamembrane domain (exon 11) of the Kit protein from amino acids 559 to 560 (UniProt.org). V559_V560del confers a gain of function on Kit, as indicated by constitutive phosphorylation of Kit, is transforming in cell culture, and promotes tumor formation in mice (PMID: 9797363). |
Associated Drug Resistance | |
Category Variants Paths |
KIT mutant KIT act mut KIT exon 11 del KIT V559_V560del KIT mutant KIT exon11 KIT exon 11 del KIT V559_V560del |
Transcript | NM_000222.3 |
gDNA | chr4:g.54727444_54727449delTTGTTG |
cDNA | c.1676_1681delTTGTTG |
Protein | p.V559_V560delVV |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000222.3 | chr4:g.54727444_54727449delTTGTTG | c.1676_1681delTTGTTG | p.V559_V560delVV | RefSeq | GRCh38/hg38 |
NM_001385288.1 | chr4:g.54727452_54727457delGAGATA | c.1675_1680delGAGATA | p.E559_I560delEI | RefSeq | GRCh38/hg38 |
NM_001385284.1 | chr4:g.54727440_54727445delAAGGTT | c.1675_1680delAAGGTT | p.K559_V560delKV | RefSeq | GRCh38/hg38 |
NM_001385292.1 | chr4:g.54727452_54727457delGAGATA | c.1675_1680delGAGATA | p.E559_I560delEI | RefSeq | GRCh38/hg38 |
XM_017008178.1 | chr4:g.54727444_54727449delTTGTTG | c.1676_1681delTTGTTG | p.V559_V560del | RefSeq | GRCh38/hg38 |
XM_017008178 | chr4:g.54727444_54727449delTTGTTG | c.1676_1681delTTGTTG | p.V559_V560del | RefSeq | GRCh38/hg38 |
NM_000222.2 | chr4:g.54727444_54727449delTTGTTG | c.1676_1681delTTGTTG | p.V559_V560del | RefSeq | GRCh38/hg38 |
NM_001385290.1 | chr4:g.54727440_54727445delAAGGTT | c.1675_1680delAAGGTT | p.K559_V560delKV | RefSeq | GRCh38/hg38 |
NM_001385286.1 | chr4:g.54727455_54727460delATAAAT | c.1675_1680delATAAAT | p.I559_N560delIN | RefSeq | GRCh38/hg38 |
NM_000222 | chr4:g.54727444_54727449delTTGTTG | c.1676_1681delTTGTTG | p.V559_V560del | RefSeq | GRCh38/hg38 |
NM_001385285.1 | chr4:g.54727444_54727449delTTGTTG | c.1676_1681delTTGTTG | p.V559_V560delVV | RefSeq | GRCh38/hg38 |
NM_001093772.2 | chr4:g.54727455_54727460delATAAAT | c.1675_1680delATAAAT | p.I559_N560delIN | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
KIT V559_V560del | Advanced Solid Tumor | sensitive | Sunitinib | Preclinical - Cell culture | Actionable | In a preclinical study, transformed cells expressing KIT V559_V560del were sensitive to Sutent (sunitinib), demonstrating decreased cell proliferation in culture (PMID: 24205792). | 24205792 |
KIT V559_V560del | Advanced Solid Tumor | sensitive | Imatinib | Preclinical - Cell culture | Actionable | In a preclinical study, transformed cells expressing KIT V559_V560del were sensitive to Gleevec (imatinib), demonstrating decreased cell proliferation in culture (PMID: 24205792). | 24205792 |
KIT V559_V560del | Advanced Solid Tumor | sensitive | Flumatinib | Preclinical - Cell culture | Actionable | In a preclinical study, transformed cells expressing KIT V559_V560del were sensitive to Flumatinib, demonstrating decreased cell proliferation in culture (PMID: 24205792). | 24205792 |